✦ LIBER ✦

Combination of hyperthermia (HT) and chemotherapy (CT) for hepatic tumors (HT) a phase I study

✍ Scribed by Tsamas, A.; diPalma, M.; Adam, R.; Ionescu-Goga, M.; Magi, M.; Rotarski, M.; Sidi, J.; Vannetzel, J.M.; Bismuth, M.; Jasmin, C.

Book ID: 122404240
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 164 KB
Volume: 29
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(93)91268-P

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II study of combined cisplatin

A phase I/II study of combined cisplatin and hyperthermia treatment for refractory malignancy

✍ Daniel M. Green; Gary V. Burton; Edwin B. Cox; Dean Hanson; Joseph Moore; James 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Chemotherapy (CT) and hormonotherapy (HT

Chemotherapy (CT) and hormonotherapy (HT) as neoadjuvant treatment in luminal breast cancer patients: results from the GEICAM/2006-03, a multicenter, randomized, phase-II study

✍ Alba, E.; Calvo, L.; Albanell, J.; De la Haba, J. R.; Arcusa Lanza, A.; Chacon, 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 159 KB

A phase I study of a new 5HT3-receptor a

A phase I study of a new 5HT3-receptor antagonist, BRL43694A, an agent for the prevention of chemotherapy-induced nausea and vomiting

✍ Geoffrey Falkson; Adriaan J. Zyl 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 370 KB

In a phase I study of BRL43694A, a 5HT3-receptor antagonist, a single dose of 40 micrograms/kg was given to 24 patients. All patients received cytostatic treatment expected to cause nausea and vomiting. During the first 24 h, 12 patients were completely protected from nausea and vomiting, 4 experien

Phase I/II study, combination of radioth

Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: Report of a pilot study by the Radiation Therapy Oncology Group

✍ B. Emami; R.J. Myerson; C. Scott; F. Gibbs; C. Lee; C.A. Perez 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 826 KB

Phase I/II study, combination of radioth

Phase I/II study, combination of radiotherapy and hyperthermia in patients with deep-seated malignant tumors: Report of a pilot study by the radiation therapy oncology group

✍ R.J. Myerson; B. Emami; C.A. Perez; F. Gibbs; C. Lee; T. Pajak 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 131 KB

Phase I/II study of a combined gemcitabi

Phase I/II study of a combined gemcitabine, etoposide, and cisplatin chemotherapy regimen for metastatic urothelial carcinoma

✍ Tetsuro Tsukamoto; Junji Yonese; Yuhei Ohkubo; Iwao Fukui 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB

## Abstract ## BACKGROUND The authors attempted to determine the maximum tolerated dose (MTD) of gemcitabine in combination with etoposide and cisplatin as a chemotherapy regimen and investigated the safety and antitumor activity with the recommended doses of gemcitabine with etoposide and cisplat